Pathogenic obesity and nutraceuticals

Proceedings of the Nutrition Society

Volumn 70, Issue 4, 2011, Pages 426-438

  Conroy, K P ^a   Davidson, I M ^a   Warnock, M ^a  

^a QUEEN MARGARET UNIVERSITY   (United Kingdom)

Author keywords

Adipose tissue; Inflammation; Nutraceuticals; Obesity; Polyphenols

Indexed keywords

ALPHA MANGOSTIN; ALPHA TOCOPHEROL; CURCUMIN; CYANIDIN 3 O BETA GLUCOSIDE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FATTY ACID; GALLIC ACID; GAMMA MANGOSTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; LUTEOLIN; MOMORDICA CHARANTIA EXTRACT; MYRICETIN; NARINGENIN; NOBILETIN; NUTRACEUTICAL; PHLORETIN; PIOGLITAZONE; PLANT MEDICINAL PRODUCT; POLYPHENOL; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; RHAPONTIN; THEAFLAVIN; THIAZOLE DERIVATIVE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADIPOCYTE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CARBOHYDRATE DIET; CARDIOVASCULAR RISK; CELL ACTIVITY; CELL SIZE; COMORBIDITY; CONFERENCE PAPER; ENDOPLASMIC RETICULUM STRESS; ENDOTOXEMIA; FATTY ACID BLOOD LEVEL; FATTY LIVER; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPERTROPHY; HYPOXIA; INFLAMMATION; LIPID DIET; LIPOGENESIS; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROADIPOCYTE; UNFOLDED PROTEIN RESPONSE; WEIGHT REDUCTION;

ADIPOCYTES; ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATION; NUTRITIONAL STATUS; OBESITY; OXIDATIVE STRESS; WEIGHT LOSS;

EID: 80155184615     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665111001662     Document Type: Conference Paper

References (188)

1. WHO (2011) Obesity and Overweight. Available at http://www.who.int/ mediacentre/factsheets/fs311/en/index.html
2. Guh D, Zhang W, Bansback N et al. (2009) The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 9, 88
3. Bertakis KD & Azari R (2005) Obesity and the use of health care services. Obesity 13, 372-379
4. Trayhurn P & Wood IS (2004) Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355 (Pubitemid 40277057)
5. Aasheim ET, Hofso D, Hjelmesaeth J et al. (2008) Vitamin status in morbidly obese patients: A cross-sectional study. Am J Clin Nutr 87, 362-369 (Pubitemid 351226072)
6. Panagiotakos DB, Pitsavos C, Yannakoulia M et al. (2005) The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 183, 308-315 (Pubitemid 41579282)
7. Chrysohoou C, Panagiotakos DB, Pitsavos C et al. (2007) The implication of obesity on total antioxidant capacity in apparently healthy men and women: The ATTICA study. Nutr Metab Cardiovasc Dis. 17, 590-597 (Pubitemid 47302303)
8. Wintergerst ES, Maggini S & Hornig DH (2007) Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 51, 301-323 (Pubitemid 47442973)
9. DeFelice SL (1995) The nutraceutical revolution: Its impact on food industry R&D. Trends Food Sci Technol 6, 59-61
10. Gulati OP & Berry Ottaway P (2006) Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products. Toxicology 221, 75-87 (Pubitemid 43325008)
11. Ramos S (2008) Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol Nutr Food Res 52, 507-526
12. Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets. Eur J Pharmacol 545, 51-64
13. Maury E & Brichard S (2010) Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314, 1-16
14. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919
15. Lago F, Dieguez C, Gomez-Reino J et al. (2007) Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheum 3, 716-724 (Pubitemid 350187017)
16. Friedman J (2002) The function of leptin in nutrition, weight and physiology. Nutr Rev 60, s1-s14
17. Considine RV, Sinha MK, Heiman ML et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292-295 (Pubitemid 26033933)
18. Maffei M, Halaas J, Ravussin E et al. (1995) Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 1155-1161
19. Hamilton BS, Paglia D, Kwan AYM et al. (1995) Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1, 953-956
20. Lonnqvist F, Arner P, Nordfors L et al. (1995) Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1, 950-953
21. Saad MF, Damani S, Gingerich RL et al. (1997) Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82, 579-584 (Pubitemid 27068633)
22. Ostlund RE Jr, Yang JW, Klein S et al. (1996) Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 81, 3909-3913 (Pubitemid 26380395)
23. Hassink SG, Sheslow DV, de Lancey E et al. (1996) Serum leptin in children with obesity: Relationship to gender and development. Pediatrics 98, 201-203 (Pubitemid 26262130)
24. Otero M, Lago Rcaa, Lago F et al. (2005) Leptin, from fat to inflammation: Old questions and new insights. FEBS Lett 579, 295-301 (Pubitemid 40092403)
25. Sanchez-Margalet V, Martin-Romero C, Santos-Alvarez J et al. (2003) Role of leptin as an immunomodulator of blood mononuclear cells: Mechanisms of action. Clin Exp Immunol 133, 11-19 (Pubitemid 36791936)
26. Sugiura K, Tamakoshi K, Yatsuya H et al. (2008) Contribution of adipocytokines to low-grade inflammatory state as expressed by circulating C-reactive protein in Japanese men: Comparison of leptin and adiponectin. Int J Cardiol 130, 159-164
27. Arita Y, Kihara S, Ouchi N et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83 (Pubitemid 29299050)
28. Tilg H & Moschen AR (2008) Role of adiponectin and PBEF/visfatin as regulators of inflammation: Involvement in obesity-associated diseases. Clin Sci 114, 275-288 (Pubitemid 351294003)
29. Bruun JM, Lihn AS, Verdich C et al. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285, E527-E533 (Pubitemid 37010830)
30. Maeda N, Takahashi M, Funahashi T et al. (2001) PPARg ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099 (Pubitemid 33643677)
31. Ouchi N, Kihara S, Funahashi T et al. (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107, 671-674 (Pubitemid 36222590)
32. Matsushita K, Yatsuya H, Tamakoshi K et al. (2006) Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis 188, 184-189 (Pubitemid 44142540)
33. Maeda N, Shimomura I, Kishida K et al. (2002) Dietinduced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8, 731
34. Nishihara T, Matsuda M, Araki H et al. (2006) Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131, 853-861 (Pubitemid 44307068)
35. Shibata R, Sato K, Pimentel DR et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11, 1096-1103 (Pubitemid 41486832)
36. Spalding K, Arner E, Westermark P et al. (2008) Dynamics of fat cell turnover in humans. Nature 453, 783-787 (Pubitemid 351793777)
37. van Harmelen V, Skurk T, Rohrig K et al. (2003) Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women. Int J Obes Relat Metab Disord 27, 889-895 (Pubitemid 36918609)
38. Stefan N, Kantartzis K, Machann J et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168, 1609-1616
39. Zeyda M & Stulnig TM (2007) Adipose tissue macrophages. Immunol Lett 112, 61-67 (Pubitemid 47379852)
40. Margioris AN (2009) Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care 12, 129-137
41. Patel C, Ghanim H, Ravishankar S et al. (2007) Prolonged reactive oxygen species generation and nuclear factor- {kappa}B activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metab 92, 4476-4479 (Pubitemid 350074773)
42. Ghanim H, Abuaysheh S, Sia CL et al. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal. Diabetes Care 32, 2281-2287
43. Erridge C (2011) Accumulation of stimulants of Toll-like receptor (TLR)-2 and TLR4 in meat products stored at 5C. J Food Sci 76, H72-H79
44. Backhed F, Ding H, Wang T et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101, 15718-15723 (Pubitemid 39473554)
45. Cani PD, Amar J, Iglesias MA et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (Pubitemid 47025442)
46. Erridge C, Attina T, Spickett CM et al. (2007) A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286-1292 (Pubitemid 350126229)
47. Amar J, Burcelin R, Ruidavets JB et al. (2008) Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87, 1219-1223 (Pubitemid 351679761)
48. Hassanali Z, Ametaj BN, Field CJ et al. (2010) Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes Metab 12, 139-147
49. Sun L, Yu Z, Ye X et al. (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33, 1925-1932
50. Cani P, Bibiloni R, Knauf C et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481
51. Neal MD, Leaphart C, Levy R et al. (2006) Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176, 3070-3079
52. Deopurkar R, Ghanim H, Friedman J et al. (2010) Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33, 991-997
53. Brun P, Castagliuolo I, Leo VD et al. (2007) Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292, G518-G525
54. Muccioli GG, Naslain D, Backhed F et al. (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 27, 6
55. Korte G, Dreiseitel A, Schreier P et al. (2010) Tea catechins affinity for human cannabinoid receptors. Phytomedicine 17, 19-22
56. Korte G, Dreiseitel A, Schreier P et al. (2009) An examination of anthocyanins and anthocyanidins affinity for cannabinoid receptors. J Med Food 12, 1407-1410
57. Ghanim H, Sia CL, Upadhyay M et al. (2010) Orange juice neutralizes the proinflammatory effect of a high-fat, highcarbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. Am J Clin Nutr 91, 940-949
58. Ghanim H, Sia CL, Korzeniewski K et al. (2011) A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, highcarbohydrate meal. J Clin Endocrinol Metab 96, 1409-1414
59. Shizuo A, Kiyoshi T & Tsuneyasu K (2001) Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2, 675
60. Lin Y, Lee H, Berg AH et al. (2000) The lipopolysaccharideactivated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 11; 275, 24255-24263 (Pubitemid 30626513)
61. Vitseva OI, Tanriverdi K, Tchkonia TT et al. (2008) Inducible Toll-like receptor and NF-[kappa]B regulatory pathway expression in human adipose tissue. Obesity 16, 932-937 (Pubitemid 351620468)
62. Creely SJ, McTernan PG, Kusminski CM et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740-E747 (Pubitemid 46411051)
63. Bes-Houtmann S, Roche R, Hoareau L et al. (2007) Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol 127, 131-137 (Pubitemid 46147267)
64. Davis JE, Gabler NK, Walker-Daniels J et al. (2008) Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 16, 1248-1255 (Pubitemid 351770507)
65. Bumrungpert A, Kalpravidh RW, Chitchumroonchokchai C et al. (2009) Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J Nutr 139, 1185-1191
66. Lira F, Rosa J, Cunha C et al. (2011) Supplementing alphatocopherol (vitamin E) and vitamin D3 in high fat diet decrease IL-6 production in murine epididymal adipose tissue and 3T3-L1 adipocytes following LPS stimulation. Lipids Health Dis 10, 37
67. Zhang Y, Lian F, Zhu Y et al. (2010) Cyanidin-3-Ob- glucoside inhibits LPS-induced expression of inflammatory mediators through decreasing IkBa phosphorylation in THP-1 cells. Inflamm Res 59, 723-730
68. Hong Byun E, Fujimura Y, Yamada K et al. (2010) TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor. J Immunol 185, 33-45
69. Nielsen S, Guo Z, Johnson M et al. (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113, 1582-1588 (Pubitemid 39071681)
70. Arner P (2005) Human fat cell lipolysis: Biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 19, 471-482 (Pubitemid 41819214)
71. Yin J, Gao Z, He Q et al. (2009) Role of hypoxia in obesityinduced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296, E333-E342
72. Opie LH & Walfish PG (1963) Plasma free fatty acid concentrations in obesity. New Engl J Med 268, 757-760
73. Fraze E, Donner CC, Swislocki ALM et al. (1985) Ambient plasma free fatty acid concentrations in noninsulindependent diabetes mellitus: Evidence for insulin resistance. J Clin Endocrinol Metab 61, 807-811 (Pubitemid 16218472)
74. Charles M, Fontbonne A, Thibult N et al. (2001) High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: Results from the Paris prospective study. Am J Epidemiol 153, 292-298 (Pubitemid 32958654)
75. Samuel VT, Petersen KF & Shulman GI (2010) Lipidinduced insulin resistance: Unravelling the mechanism. Lancet 375, 2267-2277
76. Zhang ZF, Li Q, Liang J et al. (2010) Epigallocatechin-3-Ogallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine 17, 14-18
77. Zygmunt K, Faubert B, MacNeil J et al. (2010) Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem Biophys Res Commun 398, 178-183
78. Vishnu Prasad CN, Anjana T, Banerji A et al. (2010) Gallic acid induces GLUT4 translocation and glucose uptake activity in 3T3-L1 cells. FEBS Lett 584, 531-536
79. Strobel P, Allard C, Perez-Acle T et al. (2005) Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J 386, 471-478 (Pubitemid 40445871)
80. Wu LY, Juan CC, Hwang L et al. (2004) Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr 43, 116-124 (Pubitemid 38661225)
81. Li Y, Zhao S, Zhang W et al. (2011) Epigallocatechin-3-Ogallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo. Diabetes Res Clin Pract (In the Press)
82. McQuaid SE, Hodson L, Neville MJ et al. (2011) Downregulation of adipose tissue fatty acid trafficking in obesity. Diabetes 60, 47-55
83. Liu JF, Ma Y, Wang Y et al. (2011) Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother Res 25, 588-596
84. Shang J, Chen L, Xiao F et al. (2008) Resveratrol improves non-alcoholic fatty liver disease by activating AMPactivated protein kinase1. Acta Pharmacol Sin 29, 698-706 (Pubitemid 351799479)
85. Lin CL, Huang HC & Lin JK (2007) Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res 48, 2334-2343
86. Kim T, Davis J, Zhang AJ et al. (2009) Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Comm 388, 377-382
87. Collins QF, Liu HY, Pi J et al. (2007) Epigallocatechin-3- gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 50-AMP-activated protein kinase. J Biol Chem 282, 30143-30149 (Pubitemid 350035266)
88. Carling D (2004) The AMP-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 29, 18-24 (Pubitemid 38068476)
89. Chen J, Ma M, Lu Y et al. (2009) Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice. Planta Medica 75, 472-477
90. Ozturk F, Gul M, Ates B et al. (2009) Protecive effect of apricot (Prunus armeniaca L.) on hepatic steatosis and damage induced by carbon tetrachloride in Wistar rats. Br J Nutr 102, 1767-1775
91. Poudyal H, Campbell F & Brown L (2010) Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 140, 946-953
92. Bujanda L, Hijona E, Larzabal M et al. (2008) Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 8, 40
93. Staiger H, Staiger K, Stefan N et al. (2004) Palmitateinduced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53, 3209-3216 (Pubitemid 39564497)
94. van Dijk SJ, Feskens EJ, Bos MB et al. (2009) A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am J Clin Nutr 90, 1656-1664
95. Laine P, Schwartz E, Wang Y et al. (2007) Palmitic acid induces IP-10 expression in human macrophages via NF-kB activation. Biochem Biophys Res Commun 358, 150-155 (Pubitemid 46719095)
96. Haversen L, Danielsson KN, Fogelstrand L et al. (2009) Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 202, 382-393
97. Ajuwon KM & Spurlock ME (2005) Palmitate activates the NF-{kappa}B transcription factor and induces IL-6 and TNF{alpha} expression in 3T3-L1 adipocytes. J Nutr 135, 1841-1846 (Pubitemid 41099739)
98. Subauste AR & Burant CF (2007) Role of FoxO1 in FFAinduced oxidative stress in adipocytes. Am J Physiol Endocrinol Metab 293, E159-E164 (Pubitemid 47105929)
99. Takahashi K, Yamaguchi S, Shimoyama T et al. (2008) JNK- and I{kappa}B-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro. Am J Physiol Endocrinol Metab 294, E898-E909
100. Zhang HH, Halbleib M, Ahmad F et al. (2002) Tumor necrosis factor stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51, 2929-2935
101. Permana PA, Menge C & Reaven PD (2006) Macrophagesecreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341, 507-514 (Pubitemid 43152134)
102. Lien CC, Au LC, Tsai YL et al. (2009) Short-term regulation of tumor necrosis factor-{alpha}-induced lipolysis in 3T3-L1 adipocytes is mediated through the inducible nitric oxide synthase/nitric oxide-dependent pathway. Endocrinology 150, 4892-4900
103. Schwartz EA, Zhang WY, Karnik SK et al. (2010) Nutrient modification of the innate immune response: A novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol 30, 802-808
104. Suganami T, Nishida J & Ogawa Y (2005) A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor {alpha}. Arterioscler Thromb Vasc Biol 25, 2062-2068 (Pubitemid 41416301)
105. Shi H, Kokoeva M, Inouye K et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116, 3015-3025 (Pubitemid 44684486)
106. Nguyen MTA, Favelyukis S, Nguyen AK et al. (2007) A Subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282, 35279-35292 (Pubitemid 350232441)
107. Suganami T, Yuan X, Shimoda Y et al. (2009) Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated fatty acid/Toll-Like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ Res 105, 25-32
108. Han CY, Kargi AY, Omer M et al. (2010) Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes. Diabetes 59, 386-396
109. Erridge C & Samani NJ (2009) Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 29, 1944-1949
110. Kennedy A, Martinez K, Chuang CC et al. (2009) Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: Mechanisms of action and implications. J Nutr 139, 1-4
111. Berglund G, Ljungman S, Hartford M et al. (1982) Type of obesity and blood pressure. Hypertension 4, 692-696 (Pubitemid 13239688)
112. Lonn M, Mehlig K, Bengtsson C et al. (2010) Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 24, 326-331
113. Cinti S, Mitchell G, Barbatelli G et al. (2005) Adipocyte death defines macrophage localisation and function in adipose tissue of obese mice and humans. J Lipid Res 46, 2347-2355 (Pubitemid 41532523)
114. Cancello R, Henegar C, Viguerie N et al. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277-2286 (Pubitemid 41134253)
115. Weisberg SP, McCann D, Desai M et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808 (Pubitemid 38063703)
116. Lee YH, Nair S, Rousseau E et al. (2005) Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: Increased expression of inflammation-related genes. Diabetologia 48, 1776-1783 (Pubitemid 41317831)
117. Jernas M, Palming J, Sjoholm K et al. (2006) Separation of human adipocytes by size: Hypertrophic fat cells display distinct gene expression. FASEB J 20, 1540-1542
118. Skurk T, Alberti-Huber C, Herder C et al. (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92, 1023-1033 (Pubitemid 46465679)
119. Cancello R & Clement K (2006) Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 13, 1141-1147 (Pubitemid 44401207)
120. Gustafson B, Hammarstedt A, Andersson CX et al. (2007) Inflamed adipose tissue: A culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27, 2276-2283 (Pubitemid 350203940)
121. Rosen ED & MacDougald OA (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7, 885-896 (Pubitemid 44871415)
122. Wu Z, Rosen ED, Brun R et al. (1999) Cross-regulation of C/EBP[alpha] and PPAR[gamma] controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3, 151-158 (Pubitemid 29292616)
123. Weisberg S, Leibel R & Tortoriello D (2008) Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149, 3549-3558 (Pubitemid 351919581)
124. Ejaz A, Wu D, Kwan P et al. (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139, 919-925
125. Zhao J, Sun XB, Ye F et al. (2011) Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin. Mol Cell Biochem 10, 1-10
126. Lee YK, Lee WS, Hwang JT et al. (2008) Curcumin exerts antidifferentiation effect through AMPKa-PPARg in 3T3-L1 adipocytes and antiproliferatory effect through AMPKa-COX-2 in cancer cells. J Agric Food Chem 57, 305-310
127. Narala V, Smith M, Adapala R et al. (2009) Curcumin is not a ligand for peroxisome proliferator-activated receptor-g. Gene Ther Mol Biol 13, 20-15
128. Wolfram S, Wang Y & Thielecke F (2006) Anti-obesity effects of green tea: From bedside to bench. Mol Nutr Food Res 50, 176-187 (Pubitemid 43325659)
129. Wolfram S, Raederstorff D, Wang Y et al. (2005) TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab 49, 54-63 (Pubitemid 41094834)
130. Bose M, Lambert JD, Ju J et al. (2008) The major green tea polyphenol, ( - )-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138, 1677-1683
131. Chen N, Bezzina R, Hinch E et al. (2009) Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res 29, 784-793
132. Furuyashiki T, Nagayasu H, Aoki Y et al. (2004) Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARgamma2 and C/EBPalpha in 3T3-L1 cells. Biosci Biotechnol Biochem 68, 2353-2359 (Pubitemid 40033512)
133. Moon HS, Chung CS, Lee HG et al. (2007) Inhibitory effect of ( - )-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity 15, 2571-2582
134. Lin J, Della-Fera MA & Baile CA (2005) Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obesity 13, 982-990
135. Sakurai N, Mochizuki K, Kameji H et al. (2009) ( - )-Epigallocatechin gallate enhances the expression of genes related to insulin sensitivity and adipocyte differentiation in 3T3-L1 adipocytes at an early stage of differentiation. Nutrition 25, 1047-1056
136. Lee MJ, Maliakal P, Chen L et al. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and ( - )-epigallocatechin-3-gallate by humans. Cancer Epidemiol Biomarkers Prev 11, 1025-1032
137. Yang CS, Chen L, Lee MJ et al. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7, 351-354 (Pubitemid 28354149)
138. McLaughlin T, Deng A, Yee G et al. (2010) Inflammation in subcutaneous adipose tissue: Relationship to adipose cell size. Diabetologia 53, 369-377
139. Charriere G, Cousin B, Arnaud E et al. (2003) Preadipocyte conversion to macrophage. J Biol Chem 278, 9850-9855
140. Isakson P, Hammarstedt A, Gustafson B et al. (2009) Impaired preadipocyte differentiation in human abdominal obesity: Role of Wnt, tumor necrosis factor-a, and inflammation. Diabetes 58, 1550-1557
141. Lacasa D, Taleb S, Keophiphath M et al. (2007) Macrophage-secreted factors impair human adipogenesis: Involvement of proinflammatory state in preadipocytes. Endocrinology 148, 868-877 (Pubitemid 46143186)
142. Cousin B, Andre M, Casteilla L et al. (2001) Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol 186, 380-386 (Pubitemid 32147721)
143. Cousin B, Munoz O, Andre M et al. (1999) A role for preadipocytes as macrophage-like cells. FASEB J 13, 305-312 (Pubitemid 29072407)
144. Chung S, LaPoint K, Martinez K et al. (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147, 5340-5351 (Pubitemid 44790589)
145. Harkins JM, Moustaid-Moussa N, Chung YJ et al. (2004) Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr 134, 2673-2677 (Pubitemid 39315271)
146. Poulain-Godefroy O & Froguel P (2007) Preadipocyte response and impairment of differentiation in an inflammatory environment. Biochem Biophys Res Commun 356, 662-667 (Pubitemid 46499015)
147. Lehmann JM, Moore LB, Smith-Oliver TA et al. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor g (PPARg). J Biol Chem 270, 12953-12956
148. Okuno A, Tamemoto H, Tobe K et al. (1998) Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101, 1354-1361 (Pubitemid 28145252)
149. Huang L, Hong Y, Wong Y et al. (2008) Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br J Nutr 99, 230-239
150. Hassan M, Yazidi CE, Landrier JF et al. (2007) Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells. Biochem Biophys Res Commun 361, 208-213 (Pubitemid 47102287)
151. Saito T, Abe D & Sekiya K (2007) Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem Biophys Res Commun 357, 371-376 (Pubitemid 46603141)
152. Pasarica M, Sereda O, Redman L et al. (2009) Reduced adipose tissue oxygenation in human obesity: Evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58, 718
153. Hosogai N, Fukuhara A, Oshima K et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911 (Pubitemid 46525054)
154. Rausch ME, Weisberg S, Vardhana P et al. (2007) Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes 32, 451-463 (Pubitemid 351414814)
155. Patel S & Simon M (2008) Biology of hypoxia-inducible factor-2a in development and disease. Cell Death Differ 15, 628-634 (Pubitemid 351405065)
156. Weidemann A & Johnson R (2008) Biology of HIF-1a. Cell Death Differ 15, 621-627
157. Maumus M, Sengenes C, Decaunes P et al. (2008) Evidence of in situ proliferation of adult adipose tissue-derived progenitor cells: Influence of fat mass microenvironment and growth. J Clin Endocrinol Metab 93, 4098-4106
158. Regazzetti C, Peraldi P, Gremeaux T et al. (2009) Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 58, 95-103
159. Wang B, Wood IS & Trayhurn P (2008) Hypoxia induces leptin gene expression and secretion in human preadipocytes: Differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol 198, 127-134 (Pubitemid 352038192)
160. Ye J, Gao Z, Yin J et al. (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293, E1118-E1128 (Pubitemid 47535846)
161. Kim KH, Song MJ, Chung J et al. (2005) Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem Biophys Res Commun 333, 1178-1184 (Pubitemid 40910127)
162. Lolmede K, Dunand de Saint Front V, Galitzhy J et al. (2003) Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes 27, 1187-1195 (Pubitemid 37281666)
163. Wang B, Wood I & Trayhurn P (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Archiv 455, 479-492 (Pubitemid 47624196)
164. Silha JV, Krsek M, Sucharda P et al. (2005) Angiogenic factors are elevated in overweight and obese individuals. Int J Obes 29, 1308-1314 (Pubitemid 41679261)
165. Pang C, Gao Z, Yin J et al. (2008) Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab 295, E313-E322
166. Nishimura S, Manabe I, Nagasaki M et al. (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56, 1517-1526 (Pubitemid 46842598)
167. Singh R & Agarwal R (2003) Tumor angiogenesis: A potential target in cancer control by phytochemicals. Curr Cancer Drug Targets 3:205-217 (Pubitemid 36565762)
168. Paul SAM, Simons JW & Mabjeesh NJ (2004) HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol 200, 20-30 (Pubitemid 38720618)
169. Hatanaka M, Shimba S, Sakaue M et al. (2009) Hypoxiainducible factor-3a functions as an accelerator of 3T3-L1 adipose differentiation. Biol Pharm Bull 32, 1166-1172
170. Ozcan U, Cao Q, Yilmaz E et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461 (Pubitemid 39372439)
171. Sharma NK, Das SK, Mondal AK et al. (2008) Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J Clin Endocrinol Metab 93, 4532-4541 (Pubitemid 352789557)
172. Boden G, Duan X, Homko C et al. (2008) Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57, 2438-2444
173. Gregor M, Yang L, Fabbrini E et al. (2009) Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 58, 693-700
174. Koh EH, Park JY, Park HS et al. (2007) Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56, 2973-2981
175. Gregor MF & Hotamisligil GS (2007) Thematic review series: Adipocyte biology. Adipocyte stress: The endoplasmic reticulum and metabolic disease. J Lipid Res 48, 1905-1914 (Pubitemid 47360610)
176. Ron D & Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8, 519-529 (Pubitemid 46985379)
177. Xu C, Bailly-Maitre B & Reed J (2005) Endoplasmic reticulum stress: Cell life and death decisions. J Clin Invest 115, 2656-2664 (Pubitemid 41434389)
178. Haynes CM, Titus EA & Cooper AA (2004) Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell 15, 767-776 (Pubitemid 39194906)
179. Zhang K & Kaufman R (2008) From endoplasmic reticulum stress to the inflammatory response. Nature 454, 455-462
180. Kaufman R (2002) Orchestrating the unfolded protein reponse in health and disease. J Clin Invest 110, 1389-1398 (Pubitemid 35396907)
181. Wei Y, Wang D, Topczewski F et al. (2006) Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291, E275-E281 (Pubitemid 44035286)
182. Karaskov E, Scott C, Zhang L et al. (2006) Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic {beta}-cell apoptosis. Endocrinology 147, 3398-3407 (Pubitemid 43901131)
183. Das SK, Chu WS, Mondal AK et al. (2008) Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines. Am J Physiol Endocrinol Metab 295, E393-E400
184. Parker RA, Flint OP, Mulvey R et al. (2005) Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors. Mol Pharmacol 67, 1909-1919 (Pubitemid 41007773)
185. Malhotra J, Miao H, Zhang K et al. (2008) Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc Natl Acad Sci USA 105, 18525-18530
186. Sheikh-Ali M, Sultan S, Alamir AR et al. (2010) Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells. Diabetes Res Clin Pract 87, 161-166
187. Natsume Y, Ito S, Satsu H et al. (2009) Protective effect of quercetin on ER stress caused by calcium dynamics dysregulation in intestinal epithelial cells. Toxicology 258, 164-175
188. Pal R, Cristan EA, Schnittker K et al. (2010) Rescue of ER oxidoreductase function through polyphenolic phytochemical intervention: Implications for subcellular traffic and neurodegenerative disorders. Biochem Biophys Res Commun 392, 567-571